Optimization of physicochemical properties and safety profile of novel bacterial topoisomerase type II inhibitors (NBTIs) with activity against Pseudomonas aeruginosa (original) (raw)

Novel Bacterial Topoisomerase Inhibitors with Potent Broad-Spectrum Activity against Drug-Resistant Bacteria

Mark Craighead

Antimicrobial agents and chemotherapy, 2017

View PDFchevron_right

Oxabicyclooctane-Linked Novel Bacterial Topoisomerase Inhibitors as Broad Spectrum Antibacterial Agents

Peter Meinke

ACS Medicinal Chemistry Letters, 2014

View PDFchevron_right

The Structural Features of Novel Bacterial Topoisomerase Inhibitors That Define Their Activity on Topoisomerase IV

Martina Hrast

Journal of Medicinal Chemistry, 2022

View PDFchevron_right

NBTI 5463 Is a Novel Bacterial Type II Topoisomerase Inhibitor with Activity against Gram-Negative Bacteria and In Vivo Efficacy

Asha Nayar, Thomas Dougherty

Antimicrobial Agents and Chemotherapy, 2014

View PDFchevron_right

Type IIA topoisomerase inhibition by a new class of antibacterial agents

Alexandre Wohlkonig

Nature, 2010

View PDFchevron_right

Novel Tetrahydropyran-Based Bacterial Topoisomerase Inhibitors with Potent Anti-Gram Positive Activity and Improved Safety Profile

Michel Enderlin-Paput, Eric Ertel

View PDFchevron_right

Discovery and Optimization of Indolyl-Containing 4-Hydroxy-2-Pyridone Type II DNA Topoisomerase Inhibitors Active against Multi-Drug Resistant Gram-Negative Bacteria

Marla Weetall

Journal of medicinal chemistry, 2018

View PDFchevron_right

Recent advancements in the medicinal chemistry of bacterial type II topoisomerase inhibitors

Shalini jaswal

Bioorganic Chemistry, 2020

View PDFchevron_right

Left hand side exploration of novel bacterial topoisomerase inhibitors to improve selectivity against hERG binding

Gajanan Shanbhag, Jayashree Puttur, Anandkumar Raichurkar

ACS Medicinal Chemistry Letters, 2015

View PDFchevron_right

De Novo Design of Type II Topoisomerase Inhibitors as Potential Antimicrobial Agents Targeting a Novel Binding Region

Thomas Germe

2021

View PDFchevron_right

Cyclohexyl amide-based novel bacterial topoisomerase inhibitors with prospective GyrA-binding fragments

Martina Hrast

Future Medicinal Chemistry, 2019

View PDFchevron_right

Synthesis and Characterization of Tetrahydropyran-Based Bacterial Topoisomerase Inhibitors with Antibacterial Activity against Gram-Negative Bacteria

Michel Enderlin-Paput, Eric Ertel

View PDFchevron_right

Two Decades of Successful SAR-Grounded Stories of the Novel Bacterial Topoisomerase Inhibitors (NBTIs)

Marko Anderluh

Journal of Medicinal Chemistry

View PDFchevron_right

Exploring Left-Hand-Side substitutions in the benzoxazinone series of 4-amino-piperidine bacterial type IIa topoisomerase inhibitors

Stewart Fisher

Bioorganic & Medicinal Chemistry Letters, 2011

View PDFchevron_right

In Vitro Characterization of the Antibacterial Spectrum of Novel Bacterial Type II Topoisomerase Inhibitors of the Aminobenzimidazole Class

Mike Hamblin

Antimicrobial Agents and Chemotherapy, 2006

View PDFchevron_right

Discovery and Optimization of DNA Gyrase and Topoisomerase IV Inhibitors with Potent Activity against Fluoroquinolone-Resistant Gram-Positive Bacteria

bhavesh dhumale

Journal of Medicinal Chemistry, 2021

View PDFchevron_right

Target-Based Resistance in Pseudomonas aeruginosa and Escherichia coli to NBTI 5463, a Novel Bacterial Type II Topoisomerase Inhibitor

Adam Shapiro

Antimicrobial Agents and Chemotherapy, 2014

View PDFchevron_right

In Vitro and In Vivo Activities of PD 0305970 and PD 0326448, New Bacterial Gyrase/Topoisomerase Inhibitors with Potent Antibacterial Activities versus Multidrug-Resistant Gram-Positive and Fastidious Organism Groups

Edmund Ellsworth

Antimicrobial Agents and Chemotherapy, 2007

View PDFchevron_right

Novel N-Linked Aminopiperidine Inhibitors of Bacterial Topoisomerase Type II with Reduced pKa: Antibacterial Agents with an Improved Safety Profile

Patrick Brassil

Journal of Medicinal Chemistry, 2012

View PDFchevron_right

Topoisomerase Inhibitors Addressing Fluoroquinolone Resistance in Gram-Negative Bacteria

krunal prajapati

View PDFchevron_right

Structure activity relationship of C-2 ether substituted 1,5-naphthyridine analogs of oxabicyclooctane-linked novel bacterial topoisomerase inhibitors as broad-spectrum antibacterial agents (Part-5)

Yasumichi Fukuda

Bioorganic & Medicinal Chemistry Letters, 2015

View PDFchevron_right

Structure–activity relationships of 3-aminoquinazolinediones, a new class of bacterial type-2 topoisomerase (DNA gyrase and topo IV) inhibitors

Rajeshwar Singh

Bioorganic & Medicinal Chemistry Letters, 2007

View PDFchevron_right